ELI LILLY Aktie

 

TRex Bio Inc., an early-stage biotech company focused on autoimmune and inflammatory diseases, raised $116.7 million in a US initial public offering that priced at the bottom of its marketed range....

Eli Lilly's GLP-1 momentum, new drugs and M&A deals support growth, while pricing pressure and competition pose headwinds....

Eli Lilly's obesity lead is only the starting point. See what its pipeline, manufacturing build-out, pricing pressure, and earnings trajectory could mean for the stock's next chapter....

When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?...

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards....

LLY's oncology portfolio is poised for growth as Jaypirca, Inluriyo and Retevmo may offset slower Verzenio sales and mature-drug declines....

Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit on October 20-21 in Boston, Veeva Systems (NYSE:......

The company is far from a one-trick pony....

Eli Lilly's two blockbuster drug approvals that transformed the company into a pharmaceutical giant turned out to be the worst moments to buy the stock. The entry point that crushed every other came during a moment most investors wanted nothing to do with the market....

Schnelle Gewinne verspricht die Biotechnologie zwar nicht. Die auf die Branche spezialisierte VC-Gesellschaft Forbion hat nun trotzdem Geldgeber wie KfW Capital und Eli Lilly erneut von sich und den Aussichten in der Branche überzeugt....

The World Health Organization (WHO) issued a strong recommendation against the use of weight-loss drugs for children under the age of 10, saying that the long-term effects of these powerful medicines on the human body remain unclear. Current market leaders Eli Lilly and Company (LLY.US) and Novo Nordisk are accelerating tests of......

People have long been willing to pay for healthcare despite rising costs, with Medtronic and Eli Lilly offering two different angles on the space....

Eli Lilly (LLY) closed at $1 in the latest trading session, marking a +1.26% move from the prior day....

Eli Lilly built its reputation on weight loss drugs, but a fast-growing portfolio in oncology, immunology, and neuroscience just posted triple-digit gains, and Wall Street is only beginning to price in what comes next....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Eli Lilly's revenue surged 44.7% in 2025, but Novo Nordisk trades at less than a quarter of its valuation multiple, a stark contrast that reshapes the risk-reward calculus....

Abnehmmedikamente von Novo und Eli Lilly verändern die Gesundheitsbranche. Viele Leidende finden endlich Hilfe, viele Folgeerkrankungen können vermieden werden. Doch die Abnehmmittel könnten auch auf andere Branchen erheblichen Einfluss haben wie die Lebensmittelbranche....

The healthcare stock's elevated valuation bakes in high expectations, leaving little room for error....

Eli Lilly is partnering with Ginkgo Bioworks on drug discovery....

LLY's Jaypirca gains FDA approval for first-line CLL/SLL, with strong trial results and rising sales bolstering its cancer portfolio....